This has important implications for the use of AKT inhibitors suggesting that synergistic combinations with drugs that enhance apoptosis would be predicted to be more clinically efficacious than single agent treatment, which may only cause temporary tumour growth arrest. The gene discussed is AKT1; the disease is neoplasm.